India is known as the "Pharmacy of the World" for its low-cost generic medicines, but a quieter revolution is underway in a different category: biosimilars. These are near-copies of complex…
Indian drugmakers are pushing deeper into the United States biologics market. Dr. Reddy's is reported by multiple financial media outlets in early August 2026 to have secured approval from the…
Trump Unveils Phased Generic Drug Tariff Plan President Donald Trump has announced a phased tariff plan targeting imported generic pharmaceutical products, with rates escalating from 0% initially to 100% by…
On July 21-22, 2026, President Donald Trump unveiled a phased tariff plan on imported generic drugs, targeting the reshoring of pharmaceutical manufacturing to the United States. The announcement sent shockwaves…